Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-000507

VP, CFO AND SECRETARY acquired 18,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2022-01-11 Option exercise +18,750 $1.00 $18,750 94,571 D
Derivatives
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2022-01-11 Option exercise · Stock Option (Right to Buy) −18,750 15,625 D
Loading xslF345X03/form4-01122022_020137.xml…